Company
ImmunOs Therapeutics
HARNESSING THE IMMUNE SYSTEM TO TREAT CANCER AND INFLAMMATORY DISEASES
Also known as ImmunOs Therapeutics AG
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Legal name
- ImmunOs Therapeutics AG
Claim, correct or request removal
Record updated 28 September 2026
About
The Company’s mission is to develop the next generation of novel immunotherapeutics that will improve the lives of patients with serious diseases.
Funding snapshot
- Total raised
- $85MSum of rounds, as of 2026-09-17Source (opens in a new tab)
- Latest round
- Undisclosed, $11M2024-09-17
Funding rounds
- Round, 2024
- $11M2024-09-17, Company stated
- Series B
- $74M2022-06-07, Company stated
- Grant
- 2021-04-12
- Series A
- 2019-12-10
- Round, 2018
- 2018-09-18
Loading relationship preview